Semi-Annual Statement Of Cash Flows

STELLA PHARMA CORPORATION - Filing #7320249

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-875,132,000 JPY
-824,680,000 JPY
Interest paid
-2,084,000 JPY
-2,580,000 JPY
Income taxes paid
-2,851,000 JPY
-3,630,000 JPY
Net cash provided by (used in) operating activities
-876,837,000 JPY
-827,669,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-10,978,000 JPY
-25,404,000 JPY
Other, net
180,000 JPY
-595,000 JPY
Net cash provided by (used in) investing activities
-9,010,000 JPY
-29,925,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-160,008,000 JPY
-160,008,000 JPY
Purchase of treasury shares
JPY
-30,000 JPY
Net cash provided by (used in) financing activities
228,353,000 JPY
291,819,000 JPY
Net increase (decrease) in cash and cash equivalents
-657,493,000 JPY
-565,775,000 JPY
Cash and cash equivalents
2,012,233,000 JPY
2,669,727,000 JPY
3,235,502,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.